| Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape C Zylberberg, S Matosevic Drug delivery 23 (9), 3319-3329, 2016 | 638 | 2016 |
| Stepwise synthesis of giant unilamellar vesicles on a microfluidic assembly line S Matosevic, BM Paegel Journal of the American Chemical Society 133 (9), 2798-2800, 2011 | 237 | 2011 |
| Engineering liposomal nanoparticles for targeted gene therapy C Zylberberg, K Gaskill, S Pasley, S Matosevic Gene therapy 24 (8), 441-452, 2017 | 198 | 2017 |
| Layer-by-layer cell membrane assembly S Matosevic, BM Paegel Nature chemistry 5 (11), 958-963, 2013 | 163 | 2013 |
| Natural killer cells as allogeneic effectors in adoptive cancer immunotherapy KB Lupo, S Matosevic Cancers 11 (6), 769, 2019 | 159 | 2019 |
| Immunotherapy in Lung Cancer: Current Landscape and Future Directions H Mamdani, S Matosevic, AB Khalid, G Durm, SI Jalal Frontiers in Immunology, 366, 2022 | 133 | 2022 |
| Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells J Wang, KB Lupo, AM Chambers, S Matosevic Journal for immunotherapy of cancer 6, 1-14, 2018 | 133 | 2018 |
| Fundamentals and applications of immobilized microfluidic enzymatic reactors S Matosevic, N Szita, F Baganz Journal of Chemical Technology & Biotechnology 86 (3), 325-334, 2011 | 126 | 2011 |
| Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies S Matosevic Journal of Immunology Research 2018, 2018 | 105 | 2018 |
| Adenosinergic signaling alters natural killer cell functional responses AM Chambers, J Wang, KB Lupo, H Yu, NM Atallah Lanman, S Matosevic Frontiers in Immunology 9, 2533, 2018 | 98 | 2018 |
| Immunometabolic dysfunction of natural killer cells mediated by the hypoxia-CD73 axis in solid tumors AM Chambers, S Matosevic Frontiers in Molecular Biosciences 6, 60, 2019 | 90 | 2019 |
| CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma KB Lupo, S Matosevic Journal of Hematology & Oncology 13 (1), 1-10, 2020 | 84 | 2020 |
| Tumor microenvironment-induced immunometabolic reprogramming of natural killer cells AM Chambers, KB Lupo, S Matosevic Frontiers in Immunology 9, 2517, 2018 | 79 | 2018 |
| Immobilised enzyme microreactor for screening of multi-step bioconversions: Characterisation of a de novo transketolase-ω-transaminase pathway to synthesise … S Matosevic, GJ Lye, F Baganz Journal of biotechnology 155 (3), 320-329, 2011 | 77 | 2011 |
| Synthesizing artificial cells from giant unilamellar vesicles: State‐of‐the art in the development of microfluidic technology S Matosevic BioEssays 34 (11), 992-1001, 2012 | 68 | 2012 |
| Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells J Wang, S Toregrosa-Allen, BD Elzey, S Utturkar, NA Lanman, ... Proceedings of the National Academy of Sciences 118 (45), e2107507118, 2021 | 54 | 2021 |
| Chemokine networks modulating natural killer cell trafficking to solid tumors X Yao, S Matosevic Cytokine & Growth Factor Reviews, 2021 | 52 | 2021 |
| Adenosinergic signaling as a target for natural killer cell immunotherapy J Wang, S Matosevic Journal of Molecular Medicine, 1-11, 2018 | 50 | 2018 |
| NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma J Wang, S Matosevic Journal of clinical medicine 8 (10), 1526, 2019 | 43 | 2019 |
| Design and characterization of a prototype enzyme microreactor: quantification of immobilized transketolase kinetics S Matosevic, GJ Lye, F Baganz Biotechnology progress 26 (1), 118-126, 2010 | 41 | 2010 |
